News
Fosfomicin JGL in JGL’s prescription portfolio
At the end of 2017, JGL enriched its prescription portfolio with a new product.
To make this website run properly and to improve your experience, we use cookies. For more detailed information, please check our Privacy and personal data protection.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.